Consolidated Statements Of Cash Flows (Parenthetical) (USD $)	Mar. 31, 2010	Mar. 23, 2005 Insert Therapeutics, Inc [Member]	Feb. 28, 2010 Calando Pharmaceuticals, Inc [Member]	Nov. 30, 2009 Calando Pharmaceuticals, Inc [Member]	Mar. 31, 2006 Calando Pharmaceuticals, Inc [Member]	Sep. 28, 2009 Unidym, Inc [Member]	Apr. 23, 2008 Unidym, Inc [Member]	Apr. 29, 2008 MASA Energy LLC [Member]	Aug. 08, 2008 Nanoconduction, Inc [Member]	Apr. 20, 2007 Series E Preferred Stock [Member] Carbon Nanotechnologies, Inc [Member]	Sep. 30, 2010 Series A Preferred Stock [Member] Calando Pharmaceuticals, Inc [Member]	Sep. 22, 2009 Series A Preferred Stock [Member] Unidym, Inc [Member]	Jun. 11, 2009 Series A Preferred Stock [Member] Unidym, Inc [Member]	Nov. 30, 2009 Series C Preferred Stock [Member] Unidym, Inc [Member]	Jun. 25, 2009 Series C Preferred Stock [Member] Unidym, Inc [Member]	Sep. 30, 2009 Series C-1 Preferred Stock [Member] Unidym, Inc [Member]
Purchase of common shares		7,375,000	200,000	2,850,000	964,000		200,000				1,562.5
Common stock, shares issued		50,226	8,000	114,000	20,838	64,227	7,054	10,504	11,411	143,122		9,149	132,462	15,317	194,444	27,777
Common stock value		$ 2,000,000		$ 706,800	$ 1,077,333	$ 398,209		$ 310,000	$ 250,000	$ 5,400,000		$ 46,662	$ 688,802	$ 47,485	$ 972,222	$ 186,111
Value of common stock purchased					1,928,000		200,000	560,000
Stock purchased by cash					$ 850,667			$ 250,000
Warrants issued			2,400	24,000							390,625
Warrants purchased			60,000	600,000
Common stock exercise value			$ 5.00								$ 5.00
Warrants exercised	24,788
Stock issued against warrants	12,870